Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada; Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, Ontario M5G1V7, Canada.
Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada.
Psychiatr Clin North Am. 2022 Mar;45(1):95-107. doi: 10.1016/j.psc.2021.11.006. Epub 2021 Nov 12.
Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.
2019 年冠状病毒病(COVID-19)相关压力源和限制因素,在缺乏社会和机构支持的情况下,导致许多人增加物质消费或复发。因此,物质使用障碍(SUD)的治疗方案已经从面对面治疗转为远程护理。本综述讨论了以下与 COVID 大流行对 SUD 患者临床护理相关的变化证据:(1)治疗可及性降低,(2)治疗需求增加,(3)向远程医疗的转变,(4)远程医疗治疗阿片类药物使用障碍,以及(5)远程医疗治疗 SUD 的注意事项。